Of note, histone demethylase KDM3A, also termed as JMJD1A, has been found to be upregulated in bladder cancer and lung adenocarcinoma while knockdown of KDM3A possesses therapeutic potential (Cho et al., 2012; Li et al., 2017). This evidence concerns the gene KDM3A and lung adenocarcinoma.